A Study of VRT106, Combined With Camrelizumab, and Apatinib for Advanced HCC
Clinical trial NCT07589244 · RECRUITING
Trial details
- NCT number
- NCT07589244
- Sponsor
- Guangzhou Virotech Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-13
- Primary completion
- 2028-12-31
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.